Napa 2019 • Request an Invite →
Managing Director, D.E. Shaw and Co., L.P.
Founder, Young Inventors
VP of Research and Special Initiatives, Google
Founder, The Haul Company
Medical College of Wisconsin director of research commercialization
CEO of Dynamis Corporation
Managing Director of Hatteras Discovery and Venture Partner at Hatteras Venture Partners
Founder and Chairman, Sycamore Networks
May 29, 2019 · San Diego
June 13, 2019 · San Francisco
December 5th, 2007
GlaxoSmithKline has written Lexington, MA-based Synta Pharmaceuticals (NASDAQ: SNTA) a check for $80 million. The payment is the first installment under a cancer-drug development agreement that could ultimately be worth $1.1 billion for the Lexington firm.
Xconomy Insight · Special Report
Get advice from the experts to help your biotech startup succeed
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.
© 2007-2019, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.